Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003641162 | SCV004377808 | uncertain significance | X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia | 2023-03-10 | criteria provided, single submitter | clinical testing | Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The threonine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. This variant has not been reported in the literature in individuals affected with MAGT1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 49 of the MAGT1 protein (p.Ala49Thr). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
3billion | RCV004731553 | SCV005329061 | likely benign | X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia; Linear skin defects with multiple congenital anomalies 2; Congenital disorder of glycosylation, type ICC | 2024-09-20 | criteria provided, single submitter | clinical testing | The hemizygous variant was found in patients diagnosed with another variant in a different gene, with no symptoms related to the gene containing the hemizygous variant. |